These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7714068)

  • 1. Endocrine therapy of prostate cancer: optimal form and timing.
    Labrie F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1066-71. PubMed ID: 7714068
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced prostate cancer. Hormonal treatment.
    de la Haba-Rodríguez J
    Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
    [No Abstract]   [Full Text] [Related]  

  • 3. [Keyrole of endocrinology in the victory against prostate cancer].
    Labrie F
    Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant hormone therapy before prostatectomy for cancer localized to the prostate].
    Boccon-Gibod L
    Prog Urol; 1997 Feb; 7(1):97-8. PubMed ID: 9116748
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormonal treatment of prostate cancer.
    Garnick MB
    N Engl J Med; 1999 Mar; 340(10):812-3. PubMed ID: 10075531
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
    Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
    BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine therapy for prostate cancer.
    Labrie F
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):845-72. PubMed ID: 1778180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonging survival in metastatic prostate cancer: the case for adrenal androgens--overview and summary of therapeutic controversies in prostatic cancer.
    Geller J
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1074-8. PubMed ID: 7714070
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New development of endocrine therapy in prostate cancer].
    Naito S
    Gan To Kagaku Ryoho; 1996 May; 23(6):684-8. PubMed ID: 8645018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant endocrine therapy in patients with locally advanced prostate cancer].
    Maeda O; Meguro N; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Hinyokika Kiyo; 1996 Oct; 42(10):821-7. PubMed ID: 8951482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine therapy for prostate cancer.
    Damber JE
    Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for blockade of adrenal as well as testicular androgens in the treatment of advanced prostate cancer.
    Geller J
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):28-35. PubMed ID: 3883502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone therapy in prostate cancer: clinical results].
    Morote-Robles J
    Rev Esp Fisiol; 1990 Mar; 46(1):59-62. PubMed ID: 1697693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete androgen blockade for the treatment of prostate cancer.
    Labrie F; Dupont A; Belanger A
    Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer].
    Tsukamoto S; Akaza H
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-based management of prostate cancer.
    D'Amico AV
    N Engl J Med; 2011 Jul; 365(2):169-71. PubMed ID: 21751910
    [No Abstract]   [Full Text] [Related]  

  • 18. [First line indications for hormonal therapy in prostate cancer].
    Boccon-Gibod L; Richaud P; Coloby P; Coulange C; Culine S; Davin JL; Soulié M; Zerbib M
    Prog Urol; 2010 Feb; 20(2):109-15. PubMed ID: 20142051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The truth is out there: an overall perspective on androgen deprivation.
    Hellerstedt BA; Pienta KJ
    Urol Oncol; 2003; 21(4):272-81. PubMed ID: 12954498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of complete androgen block before radical prostatectomy for cancer of the prostate].
    Gómez Veiga F; Lorenzo Patiño MJ; Díaz Bermúdez J; Duarte Novo J; Alvarez Castelo L; Chantada Abal V; Sánchez Rodríguez J; González Martín M
    Arch Esp Urol; 1997 May; 50(4):355-63. PubMed ID: 9313044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.